13 min listen
The Lancet Oncology: January 25, 2013
The Lancet Oncology: January 25, 2013
ratings:
Length:
7 minutes
Released:
Jan 26, 2013
Format:
Podcast episode
Description
John Farley discusses a trial of the MEK inhibitor selumetinib for the treatement of low-grade serous carcinoma of the ovary and peritoneum.Continue this conversation on social!Follow us today at...https://twitter.com/thelancet & https://Twitter.com/TheLancetOncolhttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Released:
Jan 26, 2013
Format:
Podcast episode
Titles in the series (100)
The Lancet Oncology: February 25, 2008 by The Lancet Oncology in conversation with